Evidence map›Paper›PMID 41830446›Full record

ArticleAnnals of neurology2026

Chronological Diagnostic Algorithm Predicting Neuropathology in Parkinsonism.

Daisuke Ono, Hiroaki Sekiya, Alexia R Maier, Neill R Graff-Radford, Zbigniew K Wszolek, Dennis W Dickson

Abstract read
In one paragraph

Article in Annals of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daisuke OnoDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL.ORCID 0000-0002-0238-7355
Hiroaki SekiyaDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL.ORCID 0000-0001-9683-5966
Alexia R MaierDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL.
Neill R Graff-RadfordDepartment of Neurology, Mayo Clinic, Jacksonville, FL.
Zbigniew K WszolekDepartment of Neurology, Mayo Clinic, Jacksonville, FL.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL.ORCID 0000-0001-7189-7917

Funding

Ethel Moore Alzheimer's DiseaseJST BOOST Program Japan JPMJBY24B8State of Florida Ed
6 · The paper itself

Abstract

objectivePre-mortem diagnosis of parkinsonism is often challenging due to atypical presentations, overlapping syndromes, and co-pathologies. This study aimed to develop a machine learning-based algorithm predicting neuropathology in parkinsonism using chronological clinical presentations, which has previously been underexplored.

methodsClinical information was automatically abstracted from medical records of the Mayo Clinic Brain Bank using fine-tuned Generative Pre-trained Transformer 4 models. Patients who developed parkinsonism within 3 years of disease onset were included. Six machine learning models were trained with age, sex, family history, and 197 clinical presentations paired with onset information to predict neuropathologic diagnoses, including co-pathologies.

resultsAmong 7,825 donors, 949 met inclusion criteria, representing 9 neuropathologic categories: Lewy body disease (LBD; n = 128), LBD with Alzheimer's disease (AD; n = 136), progressive supranuclear palsy (PSP; n = 303), PSP with AD (n = 56), PSP with LBD (n = 27), multiple system atrophy (MSA; n = 120), corticobasal degeneration (CBD; n = 99), AD (n = 43), and frontotemporal lobar degeneration (FTLD; n = 37). The CatBoost algorithm achieved an area under the receiver operating characteristic curve of 0.83 across the 9 diagnostic categories at 3 years after onset. Important predictors included age at onset, restricted eye movement, and tremor. The model remained robust to incomplete data, requiring only 23 of 200 parameters for reliable predictions with an area under the curve of 0.80. The algorithm was implemented into a user-friendly program providing diagnostic probabilities with visualizations of parameter contributions.

interpretationThis neuropathology-confirmed diagnostic algorithm provides a cost-effective and interpretable screening tool for parkinsonism, bridging biomarker testing and molecular-targeted therapies. ANN NEUROL 2026;99:1405-1414.

Indexed as

AlgorithmsBrainMachine LearningParkinsonian DisordersAgedAged, 80 and overFemaleHumansMaleMiddle AgedPrediction AlgorithmsPredictive Learning Models

Identifiers

PMID41830446
PMCPMC13206486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.